• The Firm
  • Practices
  • Offices
  • Lawyers
  • Careers
  • Diversity
  • Pro Bono

 

As one of the leading firms for M&A work in China, we are renowned for our work advising on complex cross-border transactions. We also advise on both public and private M&A, joint ventures, spinoffs, privatizations, direct investments, buyouts and private equity. As more and more Chinese clients look to expand outside of China, we are able to fully support them, both locally and wherever they may seek opportunities to expand globally, including the U.S., Europe, Asia, Africa and South America.

Recognition

 
  • Davis Polk is ranked among the leading law firms in M&A transactions in China and throughout Asia. Clients remark: “’I would always use Davis Polk for an international deal – its execution was really seamless…’” Chambers Global 2010

  •  All of our Beijing-based partners were listed as leading lawyers across a range of practice areas, including M&A, venture capital and securities, by Chambers Global 2010 and Chambers Asia 2010.

Notable Matters

 
  • AIG/AIA/Prudential. We advised the Federal Reserve Bank of New York in connection with AIG’s $35.5 billion unsuccessful sale of AIA, AIG’s Asian life insurance unit, to Prudential plc, a U.K.-based retail financial services company with operations in the U.K., Asia and U.S. 
  • China Investment Corporation/Bumi Resources. We advised China Investment Corporation (CIC), the Chinese sovereign wealth fund, in connection with its $1.9 billion investment in PT Bumi Resources Tbk, the largest coal mining company in Indonesia.
  • Charles River Laboratories/WuXi PharmaTech. We advised Charles River Laboratories on its approximately $1.6 billion proposed acquisition of WuXi PharmaTech, a leading ONG research and development outsourcing company with operations in China and the United States.
More >